FDA.reportPublic FDA data

roflumilast 0.3 % Topical Foam

RxCUI
2671682
RxNorm name
roflumilast 0.3 % Topical Foam
Display name
roflumilast 0.3 % Topical Foam
Full name
roflumilast 0.3 % Topical Foam
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZORYVEROFLUMILASTArcutis Biotherapeutics, Inc.f9e0b4a9-a227-4947-b00c-41fb18d165892026-06-22Warnings, Adverse reactionsExact identifier
rxcui: 2671682

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f9e0b4a9-a227-4947-b00c-41fb18d16589roflumilast 0.3 % Topical Foam [PSN] · roflumilast 3 MG/ML Topical Foam [SCD] · roflumilast 0.3 % Topical Foam [SY]36These highlights do not include all the information needed to use ZORYVE foam, 0.3%, safely and effectively. See full prescribing information for ZORYVE foam, 0.3%. ZORYVE ® (roflumilast) topical foam, 0.3% Initial U.S. Approval: 201120260130